Necrotizing Fasciitis Market Highlights
Necrotizing fasciitis is a bacterial infection that affects tissue beneath the skin, surrounding muscles, and organs. Growing geriatric population, increasing prevalence of infectious diseases and technological advancement in surgery has driven the market growth. Moreover, increasing healthcare expenditure, and rising demand for the better treatment has fueled the growth of the market. However, lack of awareness about the disease in developing economies and poor reimbursement policies in developed countries may slow the growth of this market.
The necrotizing fasciitis market trends report expects the industry size to reach USD 2,336.40 Million by 2030 at 6.2% CAGR during the forecast period 2022-2030.
Regional Analysis
The Americas dominate the global necrotizing fasciitis market owing to the presence of population suffering from bacterial infection and increasing number of surgical procedures in the hospitals. America is further segmented into North America and South America. North America holds the largest market owing to extensive use of advanced technology and developed pharmaceutical sector.
Europe accounts for the second largest market due to increasing funds, government support and increasing healthcare expenditure. Germany, France, and the U.K hold a significant share in the market owing to increasing demand of technologically advanced devices for the surgical procedures and overall growth of medical device industry.
Asia Pacific is the fastest growing market for the necrotizing fasciitis, whose growth is attributed to rising geriatric population, increasing prevalence of people suffering from bacterial infections and rapidly developing economies. Additionally, increasing healthcare expenditure and demand for new treatment options for rare diseases fuel the market growth. India and China are the major contributors to the market growth due to the rapid development of healthcare sector in these regions and increasing demand for diagnostic services.
On the other hand, the Middle East & Africa is expected witness limited growth due to limited access to the healthcare resources and lack of awareness about rare diseases. In the Middle East, the growth of the market is driven by increasing availability new diagnostic and treatment methods for various chronic and acute bacterial infections.
Segmentation
The global necrotizing fasciitis market is segmented on the basis of pathogen, types, treatment, and end users.
On the basis of the type, the market is categorized into Type I, Type II, Type III and others.
On the basis of the treatment, the market is segmented into intravenous antibiotics, surgery, hyperbaric oxygen treatment, and others.
On the basis of the end users, the market is segmented into hospitals & clinics, surgical centers, and others.
Key Players
Some of the key players holding the necrotizing fasciitis market share are Merck & Co. (U.S.), WOCKHARDT (India), Atox Bio (Israel), Teva Pharmaceutical Industries (Israel), Basilea Pharmaceutica Ltd. (Switzerland), and MELINTA THERAPEUTICS, INC. (U.S.).
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com